SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-340385
Filing Date
2021-11-24
Accepted
2021-11-24 16:22:16
Documents
14
Period of Report
2021-11-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d226925d8k.htm   iXBRL 8-K 25329
2 EX-99.1 d226925dex991.htm EX-99.1 10131
6 GRAPHIC g226925g1124233002763.jpg GRAPHIC 3253
  Complete submission text file 0001193125-21-340385.txt   167023

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA selb-20211123.xsd EX-101.SCH 2898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE selb-20211123_lab.xml EX-101.LAB 18123
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE selb-20211123_pre.xml EX-101.PRE 11409
7 EXTRACTED XBRL INSTANCE DOCUMENT d226925d8k_htm.xml XML 3388
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
SELECTA BIOSCIENCES INC (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 211447067
SIC: 2834 Pharmaceutical Preparations